{"cdcTestId":"2018-0019","testcaseName":"Hep B: Patient is 18 years - 4 days with first dose of Heplisav","vaccineGroup":"HepB","evaluationTestType":"Interval: At Absolute Minimum","forecastTestType":"Recommended based on interval","assessmentDate":"2022-10-19T00:00:00","patient":{"dob":"2004-10-23T00:00:00","gender":"F"},"evaluation":{"seriesStatus":"Not complete","administeredDoses":[{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"Hep B, adjuvanted","cvx":"189","mvx":"","evaluationStatus":"Valid","evaluationReason":null}]},"forecast":{"forecastNum":"2","earliestDate":"2022-11-16T00:00:00","recommendedDate":"2022-11-16T00:00:00","pastDueDate":"2022-12-13T00:00:00"},"doses":[{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"Hep B, adjuvanted","cvx":"189","mvx":"","evaluationStatus":"Valid","evaluationReason":null}],"dateAdded":"2018-04-11T20:00:00","dateUpdated":"2020-06-18T08:19:06.179","generalDescription":"This test case describes when a patient is administered the first dose of the Hep B (Heplisav) vaccine at 18 years - 4 days, that the dose is considered to be valid.","changedInVersion":"3.4","reasonForChange":""}